Stocks and securities in focus
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y ▼ | 5y |
|---|---|---|---|---|---|---|---|
| Viking Therapeutics Inc | -7.140% | -4.337% | 2.549% | 230.818% | 291.078% | 1342.616% | - |
| Catalyst Pharmaceutical Partners Inc | 0.380% | 5.679% | 1.684% | -7.183% | -4.794% | 272.201% | 409.470% |
| Cytokinetics Inc. | -0.840% | -4.918% | -16.547% | 66.667% | -24.183% | 198.969% | - |
| Boston Scientific | -0.720% | 0.735% | 7.031% | 41.383% | 33.165% | 92.254% | 111.289% |
| Novo Nordisk A/S ADR | 0.000% | 4.367% | 2.575% | -22.654% | 27.399% | 89.683% | 176.620% |
| Evolus Inc | -1.650% | -3.252% | 1.709% | 39.181% | 31.492% | 59.732% | - |
| Stryker Corp. | -0.260% | 0.557% | -5.043% | 17.993% | 13.751% | 45.519% | 83.772% |
| Merit Medical Systems | -1.360% | -0.685% | 9.023% | -5.229% | 6.618% | 38.095% | 44.394% |
| Ardelyx Inc. | -3.860% | -10.646% | 8.770% | 81.814% | 24.879% | 33.667% | - |
| Arca Biopharma | 3.140% | -0.613% | 11.724% | 67.876% | 108.360% | 21.805% | -94.286% |
| Adocia | -0.700% | 2.372% | -5.683% | 127.404% | -26.616% | -5.061% | -50.742% |
| Ironwood Pharmaceuticals | - | -1.316% | 1.351% | -19.786% | -26.471% | -18.033% | - |
| Fresenius SE & Co. KGaA | 1.890% | 2.252% | 12.904% | 1.274% | 1.274% | -33.333% | -43.659% |
| Biolife Solutions Inc | -3.510% | -0.602% | 3.774% | -2.941% | 10.738% | -36.392% | 14.329% |
| BeiGene Ltd ADR | -5.100% | -0.662% | 7.914% | -33.036% | -9.091% | -40.000% | - |
| Fresenius Medical Care AG & Co KGaA ADR | 3.260% | -5.941% | 8.571% | -13.636% | 1.604% | -40.994% | -47.802% |
| Chromadex Corp | -1.120% | -2.286% | -6.044% | 155.224% | 155.224% | -44.839% | - |
| Iovance Biotherapeutics Inc. | -17.160% | -19.684% | -12.954% | 46.348% | 30.379% | -53.346% | - |
| Akebia Therapeutics Inc. | -5.620% | -12.373% | -22.668% | 19.807% | -4.522% | -53.375% | - |
| Immuron | -4.630% | -8.850% | -26.429% | -8.036% | 23.353% | -55.217% | - |
| Bastide Le Confort | -1.020% | 6.339% | 28.874% | -29.874% | -29.620% | -56.707% | - |
| Ocular Therapeutix Inc. | -5.620% | -8.170% | -28.513% | -10.923% | 25.357% | -57.920% | 62.396% |
| Cardiff Oncology Inc. | -1.670% | -1.991% | -41.392% | 105.392% | 143.161% | -58.974% | -8.571% |
| Medigene AG | 1.010% | -5.145% | -31.395% | -11.940% | -7.233% | -62.516% | -83.095% |
| Cytomx Therapeutics Inc | -15.850% | -55.310% | -5.969% | 10.890% | 32.020% | -72.574% | - |
| Adaptimmune Therapeutics PLC ADR | -7.010% | -7.143% | -12.605% | -18.110% | 66.400% | -73.196% | - |
| Sage Therapeutics Inc. | 0.610% | -14.738% | -27.778% | -76.979% | -44.750% | -82.131% | - |
| Enlivex Therapeutics Ltd. | -1.380% | -4.027% | -61.141% | -43.254% | -36.161% | -82.346% | - |
| Inogen Inc. | 2.610% | 22.901% | 12.587% | -21.078% | 51.887% | -85.364% | - |
| MacroGenics Inc. | -77.710% | -78.352% | -81.918% | -53.424% | -65.844% | -88.752% | - |